Member Info for Wakojako

it is better for ananda to own the whole of the company for the future because when they eventually apply for aim listing they company needs to have at least a 30 mill market cap i understand the share price isnt doing the best atm but the work is going on in the back ground as u can see from twitter photos, just hold your ground average down if you need to because when it takes off addios amigos

https://twitter.com/AnandaPlc

get on there and have a look at the constant updates with what there doing i know the news is massive transformational stuff but it certainly shows you what is happening

its not a dillution its doubling the size of the prize and doubling the size of the company the guys want shares and what to be a part of the company instead of having 7 million quid there

all buys today gone through lol just hold on this will get back up to a penny the directors are confident they have loans note on the company aswell buy buy buy before you know it the commerical licence will be applied for and boom time

guys this is the Terms of the Acquisition theres nearly 100% upside from where we are just for this

Pursuant to the proposed terms of the Acquisition, Ananda will acquire the 50 ordinary shares of
£1.00 each in DJT Group which it does not currently own, for consideration of £7.3 million, which will
be satisfied by the issue of 790,538,866 Ordinary Shares (the “Consideration Shares”), at a deemed
price of 0.925p per share (the closing price of Ordinary Shares on 7 June 2021).
The transaction is conditional, amongst other things, on:
· The signing of a legally binding sale and purchase agreement to implement the Acquisition (which
will include customary restrictive covenant and non-compete provisions)
· Approval of the Acquisition by Ananda’s shareholders at a general meeting; and
· The receipt of tax advice with respect to certain structural aspects of the transaction
If the Acquisition proceeds to completion on the terms outlined above and no additional Ordinary
Shares are issued by the Company in the intervening period, the Vendor will be interested in
790,538,866 Consideration Shares, representing approximately 50% of the Company’s enlarged
issued share capital.
Under Rule 9 of the City Code on Takeovers and Mergers (the "Code"), and based on the interest of
the Vendor outlined above and on the current issued share capital of Ananda, the allotment of the
Consideration Shares will be subject to the Takeover Panel granting the Vendor a waiver of the
obligations which would otherwise oblige it to make a general offer to shareholders under Rule 9 of
the Code ("Rule 9 Waiver" “Whitewash”); any such Rule 9 Waiver would be subject to the approval of
independent shareholders in Ananda at a General Meeting.
There can be no guarantee that such shareholder approval will be obtained or that the Takeover
Panel will grant the Rule 9 Waiver required to effect the Acquisition.
DJT Group owns a 100% interest in DJT Plants, which holds the Licence, and 100% of Aristaeus
Elements Ltd, a company with certain knowhow about cannabis extraction.

it can be borring but you just gottta stay put because once it pops it cant stop dont worry it will be back over a penny soon

Little dropp today but alot of ppl taking the opportunity to top up or get in there's a lot of clever ppl out there

This Share has unbelievable potentially if you understand cannabis and the way they are doing things and the quantities they will be dealing in then this is a no brainner and if you understand how people are who rely on smoke for medicine they need a source from somewhere and although alot of them obtain it illegally for now if they had the opportunity to gain it legally with a prescription so therefore at a cheaper rate its a win win for everyone

Check out the insta or the Twitter to check this out they have got what looks like 50 or 60 mother plants in there if you don't know what mother plants are for they are nurtured to not go in to flower but are grown just to get massive so clones can continuesly be cut from them from them to grow more money I mean cannabis most growers will only have 1 or 2 ,mother's because they are always growing new shoots to provide more clones the fact that they have 60 odd shows that they are going for it and going for it big as style.there not messing around at all

Was in here a while back got out at 4p just took abit of a loss looking to get back in but also looking at Ananda developments (ana) lots of good things looking like there happening over there they have license to grow and are growing for research looking to switch to commercial license
But have this look already got a grow facility in Malta or am I making That up? These have money coming in but ana looks to have a lot more potential any thoughts

They have 65 plants on the go so far and they have taken 9 cuttings of each plant 585 so that's 650 plants total now that's about 10 years prison for us but a pat on the back for them

From research I reakon they will achieve approximately 400 to 500 grams a pant so we're looking at about 300 kg ish for research this is also worth gram street value at 10 and 15 quid a gram between 3 and 4.5 million and that is just the start even at whole sale still a few million get in now at the start of the season

All buys today maybe 1 sell this will slowly rise

Get on board before we take off

Suns out green is growing and that licence to grow money I mean commercial license is being organised

Ananda Developments Share News - ANA
Current Price
0.62p

0.00 0.0%
Bid Price Offer Price
0.55 0.70
High Price Low Price Open Price
0.62 0.59 0.62
Shares Traded Last Trade Market Cap (m)
616,002 16:29:43
Ananda Developments Plc Shareholder Update
Intraday Ananda Developments Chart
Intraday Ananda Developments Chart
11/03/2022 7:01am
UK Regulatory (RNS & others)

TIDMANA

11 March 2022

ANANDA DEVELOPMENTS PLC

("Ananda" or the "Company")

Shareholder Update

Ananda's ambition is to be a leading UK grower and provider of high quality,
consistent, carbon zero medical cannabis for the UK and international markets.

The Directors of Ananda provide the following update to shareholders.

Research programme

In early February 2022, 5 seeds of each of 13 strains of cannabis were planted
at the DJT Plants Limited ("DJT") medical cannabis research facility. Since
then, the DJT team has been undertaking the following activities:

* The cannabis plants have been monitored daily, water requirements and
nutrient requirements have been logged, and notes regarding the growth
performance of each plant has been recorded.
* Pruning has been undertaken to encourage the even growth of a larger number
of branches of each plant.
* Continued drafting of relevant Standard Operating Procedures (SOPs) to
ensure best practice.

The seeds planted comprise a range of high THC / low CBD strains, low THC /
high CBD strains and balanced strains. The precise cannabinoid and terpene
profile of each strain will be ascertained when the plants are sent for
analysis to Israel and UK based labs.

The next step to achieve stable strains of cannabis for potential commercial
growing will be for 9 cuttings to be taken from each plant. These cuttings
will be used for:

* Planting in the multi chapelles to start to assess the performance of the
strains in DJT's specialised growing conditions.
* Planting in the mother room so that there is a supply of mother plants
which can then be compared with later generations of the same strain.
* The self-crossing programme in which some of the plants are forced to
become males and then to pollinate the female plant from the same seed.
This will increase the genetic stability of the next generation of plants.

There are a number of other parts to the research programme which are all
designed to assist in the growing of stable strains of medical cannabis with
cannabinoid and terpene profiles found to be beneficial in the treatment of a
range of conditions. A further update on these initiatives will be provided in
due course

.

Commercial growing

As the research programme progresses, the team is now focused on developing its
commercial plans. Commercial growing and selling is dependent on the
successfully receipt of further licences from the Home Office and GMP (Good
Manufacturing Practice) certification from the Medicines and Healthcare
products Regulatory Agency (MHRA).

DJT Plants has retained a best-practice international GMP and pharmaceutical
consulting firm with experience in designing GMP compliant medical cannabis
facilities in jurisdictions with regulations similar to the UK. They will
assist in the design of DJT's cannabis manufacturing facility. As the UK is in
the early years of its medical cannabis industry, it is the opinion of DJT's
management team that an internationally experienced consultancy is best placed
to assist DJT. The conceptual manufacturing flowsheet has been created by DJT
and activities will now proceed to the more rigorous planning and design
processes to ensure optimum workflows, ease of access from the commercial
growing areas and scalability. The proposed facility will operate to GMP and
will be fully compliant under the MHRA guidelines.

Corporate

There remains one outstanding item to complete the Circular to shareholders for
the purchase of the 50% of DJT not owned by Ananda. Once final sign off is
obtained, the Circular will be posted to shareholders and the relevant General
Meeting called.

-Ends-

The lse does not show RNs so I will copy some over from advfn to share what's happening With the rest of the world

Topped up again today another £1k

Just topped up that sell is a buy will be topping up more once copl sorts it's self out this year will be the start and next year will be when we take off with commercial license
Good entry point for everyone it's not going any lower than this

Good se of results there